2024 Annual Symposium on Risks and Opportunities of AI in Pharmaceutical Medicine
June 10- 11, 2024 | Virtual and In Person at Northeastern University, Boston Campus
Generative AI in Medical Research & Drug Development: Hype or Reality?
About the Symposium
Where will the AI revolution take pharmaceutical science?
The Symposium on Risks and Opportunities of Artificial Intelligence in Pharmaceutical Medicine (AIPM), co-sponsored by Pfizer Inc, Northeastern University and the American Statistical Association (ASA), is intended to provide a forum for major stakeholders to have a dialogue on pertinent issues that have policy implications for proper implementation of this emerging technology.
Key Topics
This event is designed to serve as a platform for:
- Statisticians, data scientists, regulators, and other professionals to address the challenges and opportunities of AI in pharmaceutical medicine.
- Fostering collaboration among industry, academia, regulatory agencies, and professional associations.
- Discussing policy implications for proper implementation of AI in promoting public health.
Learn more about the conference, schedule, and presenters on the conference website.
Contact Information
For program-related queries, please reach out to:
David Madigan (d.madigan@northeastern.edu)
Demissie Alemayehu (demissie.alemayehu@pfizer.com)
For all other inquiries, please contact : AIPM@northeastern.edu
Logistics
Day 1: Tutorials
East Village Building, 17th floor
291 St. Botolph Street, Boston, MA 02115
Day 2: Meeting
Interdisciplinary Science and Engineering Complex (ISEC)
805 Columbus Ave, Boston, MA 02120
Reception
EXP Building
815 Columbus Ave, Boston, MA 02120
Location
110 Churchill Hall 360
Huntington Avenue
Boston, MA 02115
(617) 373–2000
Do you have questions for the Office of the Provost? Please reach out to us.
QUICK LINKS
CAMPUS LOCATIONS
Today, a vanguard of donors is driving Northeastern’s historic $1.75 billion campaign. With initiatives that span the globe, accelerating outcomes, we’re creating a better world right now. Learn more about our mission